Week-by-week dosage comparison Weight loss comparison at matched timepoints *Tirzepatide 24 and 48-week figures estimated from SURMOUNT-1 trajectory data, as primary endpoint was 72 weeks
Your individual results depend on factors like your starting weight, how well you follow the treatment plan, lifestyle changes you make, and your bodys unique response
TrimRX prescribes GLP-1 receptor agonists mainly semaglutide (the active ingredient in Ozempic and Wegovy) and tirzepatide (the active ingredient in Mounjaro and Zepbound)
Adults with a BMI of 27 kg/m or above who also have at least one weight-related condition, such as type 2 diabetes, high blood pressure, or dyslipidaemia
Compounded semaglutide vs
When to reassess If GI symptoms worsen instead of improving over the first 2-3 weeks, if any unusual symptom appears, or if blood glucose readings drop more than expected, pause and consult a qualified clinician